Viewing nowProcyta Tablet 50 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Ajou Pharmaceuticals Co., Ltd.

MFDS item code 202101371 · Approved 2021.02.17 · Insurance code 654006100
Improvement in blood sugar control in type 2 diabetes
This medication is used along with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be used alone or in combination with metformin if the patient has no previous experience with diabetes medication and is having difficulty controlling blood sugar alone. Additionally, it can be used in combination with sulfonylureas, metformin, thiazolidinediones, or insulin when blood sugar control is insufficient with those agents alone. In combination therapy, if blood sugar control is still inadequate despite using metformin or other agents together, this medication can be added. This medication is effective in improving blood sugar control.
This medication is administered once daily at a dose of 100 mg in monotherapy or combination therapy, with a maximum daily dose of 100 mg. It can be taken regardless of meals. For patients with renal impairment, dosage adjustments are required based on renal function. - Mild renal impairment (eGFR 60 or above but less than 90): No dosage adjustment needed - Moderate renal impairment (eGFR 45 or above but less than 60): No dosage adjustment needed - Moderate renal impairment
This medication may rarely cause serious allergic reactions; therefore, if symptoms such as skin rash, difficulty breathing, or swelling of the face or lips occur after taking the medication, stop taking it immediately and consult a doctor. Also, pancreatitis, which is inflammation of the pancreas, may occur during treatment with this medication, so if symptoms such as abdominal pain, vomiting, or loss of appetite appear, notify healthcare personnel immediately. This medication should not be used by patients with type 1 diabetes or diabetic ketoacidosis, and patients who are allergic to this medication or its components should not take it. Patients with impaired kidney function may experience slowed excretion of this medication, so dosage adjustments should be made as directed by a physician, and regular kidney function tests are important. While taking this medication, side effects such as upper respiratory infections, nasopharyngitis, headache, diarrhea, etc., may occur; if symptoms are severe or persist for a long time, consult a doctor. Particularly, when taken with insulin or sulfonylurea, hypoglycemic symptoms may occur, so blood sugar levels should be monitored regularly, and dosage adjustments may be necessary if required. Rare side effects such as severe joint pain or blistering skin diseases have also been reported, so if there is severe pain in the joints or blistering or rashes on the skin, inform healthcare personnel immediately. Pregnant or breastfeeding women should avoid using this medication as its safety has not been established, and it is not recommended for children or adolescents under 18 years of age. In case of overdose, general emergency care should be received, and if necessary, blood dialysis may be performed to remove the medication; thus, care should be taken not to exceed the prescribed dose. Finally, this medication tends to have fewer drug interactions, but if taken with cyclosporine or digoxin, changes in blood concentration may occur, so it is essential to inform the doctor about other medications being taken and to undergo regular monitoring.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, anaphylaxis, rash, exfoliative skin conditions (including Stevens-Johnson syndrome), severe rash with fever, blisters, skin peeling, oral/eye mucosal pain, acute pancreatitis, severe edema, acute kidney failure, severe and disabling joint pain, blistering pemphigoid, severe allergic reactions, severe skin adverse reactions, respiratory issues, liver abnormalities,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is best to keep the storage temperature between 1 and 30 degrees Celsius at room temperature, which will help maintain the medication's effectiveness for a prolonged period.
Light apricot-colored, round, biconvex film-coated tablet
28 tablets/box [14 tablets/PITP*2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Ajou Pharmaceuticals Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.